chr17-34252769-A-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_002982.4(CCL2) variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.287 (AC=43,619) in the gnomAD database across 152,162 control chromosomes, including 6,922 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.539. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: 𝑓 0.29 ( 6922 hom., cov: 33)

Consequence

CCL2
NM_002982.4 upstream_gene

Predictors

3
AlphaGenome AVI: 1 : Benign

Clinical Significance

Uncertain significance criteria provided, single submitter U:1B:2

Conservation

PhyloP100: -0.103

Publications

87 publications found
Genes affected
CCL2 (HGNC:10618): (C-C motif chemokine ligand 2) This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS&#8208;CoV&#8208;2) infection. [provided by RefSeq, Aug 2020]
CCL2 Gene-Disease associations (from GenCC):
  • neural tube defects, susceptibility to
    Inheritance: AD Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
ENSG00000301139 (HGNC:):

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002982.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available; Germline computational verdict: benign (Strong)
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.5392 — exceeds 5% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002982.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CCL2 NM_002982.4
MANE Select
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot: NP_002973.1

Ensembl Transcripts

CCL2 ENST00000225831.4
TSL:1MANE Select
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot: ENSP00000225831
ENSG00000301139 ENST00000776537.1
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot:
CCL2 ENST00001137144.1
HGVSc / HGVSp
Exon rankN/A
upstream_gene
Prot: ENSP00000801869

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.287
AC:43582
Hom:6908
AN:152044
Cov:33
GnomAD4 genome
AF: 0.287
AC:43619
Hom:6922
AN:152162
Cov:33
TOPMed (Bravo)
AF: 0.290
AC:76670
Hom:12496
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.279
AC:143748
Hom:21089
AN:514420
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.312
AC:730
Hom:112
AN:2342
ChinaMAP Phase 1
AF: 0.573
Denmark Genome
AF: 0.370
AC:111
AN:300
GenomeAsia100K
AF: 0.439
AC:1527
AN:3478
Korea4K (4,157 Koreans)
AF: 0.616
AC:4455
AN:7234
Qatari Genome
AF: 0.324
AC:57
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.663
AC:81432
Hom:26991
AN:122802
Turkish Variome
AF: 0.291
AC:450
Hom:73
AN:1546
UK10K
AF: 0.283
AC:2143
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.556
AC:4981
Hom:1377
AN:8960
Showing 14 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
CCL2-related disorder (2)
-
-
1
Spina bifida, susceptibility to (1)

Computational Scores

AlphaGenome AVI
Benign1.2
BayesDel_noAF
Benign-0.83
CADD
Benign0.18
DANN
Benign0.46
GPN-Star LLR
N/A0.16
GPN-Star score
N/A-0.16
PhyloP100
Benign-0.10
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.